News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Kelly Paul Edward
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 05/30/2023 |
4
| Kelly Paul Edward (Director) has filed a Form 4 on RELMADA THERAPEUTICS, INC.|
Txns:
| Granted 92,958 options to buy
@ $3.37, valued at
$313.3k
|
|
| 02/02/2023 |
5
| Form 5 - Annual statement of changes in beneficial ownership of securities: |
| 12/20/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/26/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/05/2022 |
4
| Kelly Paul Edward (Director) has filed a Form 4 on RELMADA THERAPEUTICS, INC.|
Txns:
| Sold 10,000 shares
@ $30.0395, valued at
$300.4k
Exercised 10,000 options to buy
@ $3.24, valued at
$32.4k
|
|
| 01/05/2022 |
4
| Kelly Paul Edward (Director) has filed a Form 4 on RELMADA THERAPEUTICS, INC.|
Txns:
| Exercised 20,000 options to buy
@ $3.24, valued at
$64.8k
|
|
| 12/21/2021 |
4
| Kelly Paul Edward (Director) has filed a Form 4 on RELMADA THERAPEUTICS, INC.|
Txns:
| Granted 117,530 options to buy
@ $19.03, valued at
$2.2M
|
|
| 03/11/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/26/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/10/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/03/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/29/2021 |
4
| Kelly Paul Edward (Director) has filed a Form 4 on RELMADA THERAPEUTICS, INC.|
Txns:
| Sold 1,844 shares
@ $31.69, valued at
$58.4k
Sold 2,988 shares
@ $32.89, valued at
$98.3k
Sold 168 shares
@ $33.4, valued at
$5.6k
Exercised 5,000 options to buy
@ $3.24, valued at
$16.2k
|
|
| 01/27/2021 |
4/A
| Kelly Paul Edward (Director) has filed a Form 4 on RELMADA THERAPEUTICS, INC.|
Txns:
| Sold 1,800 shares
@ $35.43, valued at
$63.8k
|
|
| 01/26/2021 |
4
| Kelly Paul Edward (Director) has filed a Form 4 on RELMADA THERAPEUTICS, INC.|
Txns:
| Sold 1,800 shares
@ $3543, valued at
$6.4M
Sold 300 shares
@ $36.18, valued at
$10.9k
Sold 1,300 shares
@ $35.27, valued at
$45.9k
Sold 685 shares
@ $35.16, valued at
$24.1k
Exercised 4,085 options to buy
@ $3.24, valued at
$13.2k
|
|
| 01/11/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/19/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/23/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/21/2019 |
4
| Kelly Paul Edward (Director) has filed a Form 4 on RELMADA THERAPEUTICS, INC.|
Txns:
| Bought 1,000 shares
@ $18.99, valued at
$19k
Bought 100 shares
@ $19.04, valued at
$1.9k
Bought 400 shares
@ $19.07, valued at
$7.6k
Bought 100 shares
@ $19.08, valued at
$1.9k
Bought 200 shares
@ $19.1, valued at
$3.8k
Bought 100 shares
@ $19.15, valued at
$1.9k
Bought 3,100 shares
@ $19.2, valued at
$59.5k
|
|
| 07/30/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/15/2019 |
4
| Kelly Paul Edward (Director) has filed a Form 4 on RELMADA THERAPEUTICS, INC.|
Txns:
| Bought 100,000 shares
@ $1.5, valued at
$150k
Bought 50,000 warrants
@ $2.25, valued at
$112.5k
|
|
| 12/20/2018 |
4
| Kelly Paul Edward (Director) has filed a Form 4 on RELMADA THERAPEUTICS, INC.|
Txns:
| Granted 500,000 options to buy
@ $1.15, valued at
$575k
|
|
| 12/11/2018 |
4
| Kelly Paul Edward (Director) has filed a Form 4 on RELMADA THERAPEUTICS, INC.|
Txns:
| Bought 5,000 shares
@ $1.213, valued at
$6.1k
|
|
| 10/19/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/23/2017 |
4
| Kelly Paul Edward (Director) has filed a Form 4 on RELMADA THERAPEUTICS, INC.|
Txns:
| Granted 450,000 options to buy
@ $0.81, valued at
$364.5k
|
|
|
|